Cargando…
A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives
The need for long-term treatments of chronic diseases has motivated the widespread development of long-acting parenteral formulations (LAPFs) with the aim of improving drug pharmacokinetics and therapeutic efficacy. LAPFs have been proven to extend the half-life of therapeutics, as well as to improv...
Autores principales: | Shi, Yujie, Lu, An, Wang, Xiangyu, Belhadj, Zakia, Wang, Jiancheng, Zhang, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424287/ https://www.ncbi.nlm.nih.gov/pubmed/34522592 http://dx.doi.org/10.1016/j.apsb.2021.05.002 |
Ejemplares similares
-
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
por: Deodhar, Suyash, et al.
Publicado: (2022) -
Parenteral Formulation of Zopiclone
por: Swamy, P. V., et al.
Publicado: (2008) -
Regulating Interactions Between Targeted Nanocarriers and Mononuclear Phagocyte System via an Esomeprazole-Based Preconditioning Strategy
por: Belhadj, Zakia, et al.
Publicado: (2020) -
Parenteral, non-live rotavirus vaccine: recent history and future perspective
por: Song, Jae Min
Publicado: (2021) -
Standardised neonatal parenteral nutrition formulations – Australasian neonatal parenteral nutrition consensus update 2017
por: Bolisetty, Srinivas, et al.
Publicado: (2020)